12:00 AM
 | 
Oct 01, 2007
 |  BioCentury  |  Finance

4Q milestones

4Q milestones

Company Product Standard indication Event Milestone
Accentia (ABPI) SinuNase Sinusitis Ph III data YE07
Acusphere (ACUS)/Nycomed Imagify (AI-700) Cardiovascular Submit NDA 4Q07
Adams Respiratory (ARXT) Extended-release guaifenesin combination Cough PDUFA date Oct. 27
Adv Life Sci (ADLS) Cethromycin Pneumonia Ph III data; submit NDA November; YE07
Aeterna Zentaris (TSX:AEZ; AEZS)/Ardana (LSE:ARA) ARD-07 (Formerly EP-1572) Growth hormone deficiency Ph III data; submit NDA November; YE07
AMAG Pharma (AMAG) Ferumoxytol Anemia Submit NDA 4Q07
Amgen (AMGN) AMG 531 Idiopathic thrombocytopenic purpura (ITP) US and EU regulatory submissions YE07
Amylin (AMLN)/Eli Lilly (LLY)/Alkermes (ALKS) Exenatide LAR Diabetes Ph III data 4Q07
Anesiva (ANSV) Zingo (3268) Pain Ph III data 4Q07
Ardana (LSE:ARA) ARD 0403 Hypogonadism Ph III data YE07
Arpida (SWX:ARPN) Iclaprim (AR-100, Ro-48-2622) Skin and skin structure infection (SSSI) Submit NDA 4Q07
BioDelivery...

Read the full 985 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >